136 related articles for article (PubMed ID: 38141237)
1. Revisiting Screening in Women With a Family History of Breast Cancer.
Coffey K; Mango V
J Breast Imaging; 2023 Nov; 5(6):635-645. PubMed ID: 38141237
[TBL] [Abstract][Full Text] [Related]
2. ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density.
; Weinstein SP; Slanetz PJ; Lewin AA; Battaglia T; Chagpar AB; Dayaratna S; Dibble EH; Goel MS; Hayward JH; Kubicky CD; Le-Petross HT; Newell MS; Sanford MF; Scheel JR; Vincoff NS; Yao K; Moy L
J Am Coll Radiol; 2021 Nov; 18(11S):S456-S473. PubMed ID: 34794600
[TBL] [Abstract][Full Text] [Related]
3. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.
Melnikow J; Fenton JJ; Whitlock EP; Miglioretti DL; Weyrich MS; Thompson JH; Shah K
Ann Intern Med; 2016 Feb; 164(4):268-78. PubMed ID: 26757021
[TBL] [Abstract][Full Text] [Related]
4. The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening.
Chau SL; Alabaster A; Luikart K; Brenman LM; Habel LA
J Prim Care Community Health; 2017 Apr; 8(2):55-62. PubMed ID: 27799412
[TBL] [Abstract][Full Text] [Related]
5. Breast density implications and supplemental screening.
Vourtsis A; Berg WA
Eur Radiol; 2019 Apr; 29(4):1762-1777. PubMed ID: 30255244
[TBL] [Abstract][Full Text] [Related]
6. Performance of Supplemental Imaging Modalities for Breast Cancer in Women With Dense Breasts: Findings From an Umbrella Review and Primary Studies Analysis.
Lobig F; Caleyachetty A; Forrester L; Morris E; Newstead G; Harris J; Blankenburg M
Clin Breast Cancer; 2023 Jul; 23(5):478-490. PubMed ID: 37202338
[TBL] [Abstract][Full Text] [Related]
7. Should This Woman With Dense Breasts Receive Supplemental Breast Cancer Screening?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
Smetana GW; Elmore JG; Lee CI; Burns RB
Ann Intern Med; 2018 Oct; 169(7):474-484. PubMed ID: 30285208
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of supplemental breast cancer screening modalities to mammography or digital breast tomosynthesis in women with heterogeneously and extremely dense breasts and average or intermediate breast cancer risk in US healthcare.
Blankenburg M; Sánchez-Collado I; Soyemi BO; Åkerborg Ö; Caleyachetty A; Harris J; Morris E; Newstead G; Lobig F
J Med Econ; 2023; 26(1):850-861. PubMed ID: 37278659
[TBL] [Abstract][Full Text] [Related]
9. Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
Sorin V; Yagil Y; Yosepovich A; Shalmon A; Gotlieb M; Neiman OH; Sklair-Levy M
AJR Am J Roentgenol; 2018 Nov; 211(5):W267-W274. PubMed ID: 30240292
[TBL] [Abstract][Full Text] [Related]
10. Supplemental Breast Cancer Screening in Women with Dense Breasts and Negative Mammography: A Systematic Review and Meta-Analysis.
Hussein H; Abbas E; Keshavarzi S; Fazelzad R; Bukhanov K; Kulkarni S; Au F; Ghai S; Alabousi A; Freitas V
Radiology; 2023 Mar; 306(3):e221785. PubMed ID: 36719288
[TBL] [Abstract][Full Text] [Related]
11. Tailored supplemental screening for breast cancer: what now and what next?
Berg WA
AJR Am J Roentgenol; 2009 Feb; 192(2):390-9. PubMed ID: 19155400
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR.
Monticciolo DL; Newell MS; Moy L; Lee CS; Destounis SV
J Am Coll Radiol; 2023 Sep; 20(9):902-914. PubMed ID: 37150275
[TBL] [Abstract][Full Text] [Related]
13. Risk-based Breast Cancer Screening: Implications of Breast Density.
Lee CI; Chen LE; Elmore JG
Med Clin North Am; 2017 Jul; 101(4):725-741. PubMed ID: 28577623
[TBL] [Abstract][Full Text] [Related]
14. Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial.
Saadatmand S; Rutgers EJ; Tollenaar RA; Zonderland HM; Ausems MG; Keymeulen KB; Schlooz-Vries MS; Koppert LB; Heijnsdijk EA; Seynaeve C; Verhoef C; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MM
BMC Cancer; 2012 Oct; 12():440. PubMed ID: 23031619
[TBL] [Abstract][Full Text] [Related]
15. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
Geuzinge HA; Obdeijn IM; Rutgers EJT; Saadatmand S; Mann RM; Oosterwijk JC; Tollenaar RAEM; de Roy van Zuidewijn DBW; Lobbes MBI; van 't Riet M; Hooning MJ; Ausems MGEM; Loo CE; Wesseling J; Luiten EJT; Zonderland HM; Verhoef C; Heijnsdijk EAM; Tilanus-Linthorst MMA; de Koning HJ;
JAMA Oncol; 2020 Sep; 6(9):1381-1389. PubMed ID: 32729887
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
18. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.
Warner E; Messersmith H; Causer P; Eisen A; Shumak R; Plewes D
Ann Intern Med; 2008 May; 148(9):671-9. PubMed ID: 18458280
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk characteristics of women undergoing whole-breast ultrasound screening versus mammography alone.
Sprague BL; Ichikawa L; Eavey J; Lowry KP; Rauscher G; O'Meara ES; Miglioretti DL; Chen S; Lee JM; Stout NK; Mandelblatt JS; Alsheik N; Herschorn SD; Perry H; Weaver DL; Kerlikowske K
Cancer; 2023 Aug; 129(16):2456-2468. PubMed ID: 37303202
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
